The search for a cure

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer massa nulla, tincidunt id magna et, rutrum congue mauris. Nullam a commodo libero, ac pellentesque sapien. Fusce rhoncus urna non risus convallis, et efficitur lorem bibendum. Nulla sed libero posuere, dictum nunc vel, lacinia sem. Donec non mollis massa. Integer ornare sit amet nulla ac consequat. Nullam ut mi sed erat dictum semper sit amet iaculis mi.

Integer magna tortor, ullamcorper at ligula in, ultrices vestibulum sapien. Ut fringilla arcu eu velit blandit vestibulum. Mauris eget magna et purus euismod facilisis. Proin nisi mi, luctus ut pulvinar non, cursus eget sapien. Quisque faucibus vel mi nec tempus. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec vel arcu nec mi scelerisque sodales suscipit in metus. In hac habitasse platea dictumst. Ut eget consectetur nisl. Vestibulum ornare bibendum justo vitae feugiat. Nam mattis lorem et aliquam lobortis. Suspendisse a est semper, tempor sapien ac, rutrum massa. Ut vitae libero et sem cursus rutrum. Vestibulum id nibh tempor, suscipit felis ut, egestas ligula. Phasellus placerat efficitur sem.

In non massa nec ipsum scelerisque viverra vel ac nisl. Nulla congue mauris id massa aliquam, a fringilla turpis elementum. Pellentesque erat justo, faucibus pulvinar tellus sed, volutpat interdum justo. Mauris cursus, ante in egestas mollis, diam leo varius libero, eu euismod mauris libero euismod lacus. Pellentesque maximus ultricies mauris quis posuere. Etiam leo mauris, feugiat vitae lorem id, placerat rutrum nulla. Integer ullamcorper porttitor augue at ultrices. Praesent efficitur ligula at placerat sodales.

Latest news

Cystic Fibrosis expert from Imperial named on clinical advisory board for Proteostasis Therapeutics

Cystic Fibrosis expert from Imperial named on clinical advisory board for Proteostasis Therapeutics

Professor Jane Davies of Imperial College London has been appointed to Proteostasis Therapeutics’ Cystic Fibrosis clinical advisory board, in a collaboration facilitated by Imperial Consultants (ICON). read more

Imperial’s COVID-19 vaccine explained

Imperial’s COVID-19 vaccine explained

As the first trials of Imperial’s COVID-19 vaccine candidate got underway in June, Professor Robin Shattock, Dr Katrina Pollock and Dr David Owen explain how the vaccine works, how it’s being trialled, and plans to help it reach populations around the world, if it proves to be effective in protecting people against COVID-19. read more

Global methane emissions rising at alarming rate

Global methane emissions rising at alarming rate

Our analysis shows that increased human activities are the most likely cause advises Dr Apostolos Voulgarakis. The Global Methane Budget charts the sources and sinks of global methane from our atmosphere. Its 2016 update shows that methane in the atmosphere has increased by 150 percent since the year 1750, and is responsible for 20 percent of the global warming produced by all greenhouse gases so far. read more

Related case studies

Global adoption and regulation of electronic medical records

Global adoption and regulation of electronic medical records

Our consultants shared their expertise in clinical medicine to help IMS Health to assess the adoption, governance and regulatory landscape of electronic medical records (EMR) at different levels of healthcare systems around the world. read more

Design advice on eco-ventilation system for homes

Design advice on eco-ventilation system for homes

Our consultants shared their expertise in sustainable energy system design to help Clean Tech start up ‘Ventive Ltd’ to move into new markets with their PVHR (passive ventilation with heat recovery) system. read more

Cystic Fibrosis clinical advisory board

Cystic Fibrosis clinical advisory board

Our consultants shared their expertise in Cystic Fibrosis (CF), drug development and clinical trials to help Proteostasis Therapeutics assess the combination of compounds aimed at treatments to improve lung function. read more